[1] Allan G, Krakowka S, Ellis J, et al.Discovery and evolving history of two genetically related but phenotypically different viruses, porcine circoviruses 1 and 2[J].Virus Res, 2012, 164(1-2):4-9.
[2] Opriessnig T,Meng X J, Halbur P G. Porcine circovirus type 2-associated disease:Update on current terminology, clinical manifestations,pathogenesis,diagnosis, and intervention strategies[J].J Vet Diagn Invest, 2007, 19(6):591-615.
[3] Rovira A, Balasch M, Segalés J,et al.Experimental inoculation of conventional pigs with porcine reproductive and respiratory syndrome virus and porcine circovirus 2[J]. J Virol, 2002, 76(7):3232-3239.
[4] Wu P C,Chien M S,Tseng Y Y,et al.Expression of the porcine circovirus type 2 capsid protein subunits and application to an indirect ELISA[J]. J Biotechnol, 2008, 133(1):58-64.
[5] Mamat U,Wilke K,Bramhill D, et al. Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins[J]. Microb Cell Fact, 2015, 14:57-70.
[6] Dalton A C, Barton W A, Over-expression of secreted proteins from mammalian cell lines[J]. Protein Sci, 2014, 23(5):517-525.
[7] Bill R M. Recombinant protein subunit vaccine synthesis in microbes:A role for yeast[J].J Pharm Pharmacol, 2015, 67(3):319-328.
[8] Kim H J. Yeast as an expression system for producing virus-like particles:What factors do we need to consider[J]. Lett Appl Microbiol, 2017, 64(2):111-123.
[9] 姜晶, 敖日格乐, 王纯洁, 等.酸马奶提取植物乳杆菌DSM20174细菌素的理化特性研究[J]. 中国畜牧兽医, 2016, 43(2):444-449.
[10] Bermúdez-Humarán L G,Aubry C,Motta J P, et al. Engineering lactococci and lactobacilli for human health[J]. Curr Opin Microbiol, 2013, 16(3):278-283.
[11] Kawana K,Adachi K,Kojima S, et al.Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3(CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients[J]. Vaccine, 2014, 32(47):6233-6239.
[12] Veloso T R,Mancini S,Giddey M, et al.Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA[J].Vaccine, 2015, 33(30):3512-3517.
[13] Norton P M,Wells J M,Brown H W,et al. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C[J]. Vaccine, 1997, 15(6-7):616-619.
[14] Shi S H,Yang W T,Yang G L, et al.Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarum NC8 expressing hemagglutinin in BALB/c mice[J]. Virology,2014, 12(464-465):166-176.
[15] Wang Z H,Cao X H,Du X G, et al. Mucosal and systemic immunity in mice after intranasal immunization with recombinant Lactococcus lactis expressing ORF6 of PRRSV[J]. Cell Immunol, 2014, 287(2):69-73.
[16] 钟泽民, 赖强, 余希尧, 等.猪表皮生长因子在植物乳杆菌中的表达及其活性检测[J]. 生物工程学报,2015, 31(9):1325-1334.
[17] Mason C K,Collins M A,Thompson K. Modified electroporation protocol for Lactobacilli isolated frorn thechicken crop facilitates transformation and the use of a genetic tool[J]. J Microbol Methods, 2005, 60(3):353-363.
[18] Dieye Y,Usai S,Clier F, et al.Design of a protein-targeting system for lactic acid bacteria[J]. J Bacteriol, 2001, 183(14):4157-4166.
[19] 胡梦莎.花生过敏重组乳酸菌口服疫苗的制备及其效果的评价[D]. 无锡:江南大学, 2013.
[20] Bucarey S A,Noriega J,Reyes P, et al.The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts[J]. Vaccine,2009, 27(42):5781-5790.
[21] Bucarey S A,Pujol M,Poblete J, etal.Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration[J].Virol J, 2014, 11(1):149.
[22] Truong C,Mahe D,Blanchard P, et al.Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection[J]. Arch Virol, 2001, 146(6):1197-1211.
[23] Nawagitgul P,Morozov I,Bolin S R, et al. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein[J]. J Gen Virol,2000, 81(9):2281-2287.
[24] 赵燕, 喻正军.猪圆环病毒2型基因组DNA的结构与功能研究进展[J]. 中国畜牧兽医, 2016, 43(5):1176-1181.
[25] Hanniffy S B,Carter A T,Hitchin E, et al. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection[J]. J Infect Dis, 2007, 195(2):185-193.
[26] Li X,Xing Y,Guo L, et al.Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice[J]. Pathog Dis, 2014, 72(1):78-86. |